Browsing: FDA

STAT’s Jason Mast joins the podcast from Shanghai, where he’s digging into what the rise of Chinese drug development means for the biotech industry. The hosts also speak to colleague Margaret Manto about Heidi Overton, the president’s pick to be commissioner of the Food and Drug Administration. Will the new nominee bring some needed stability…

Heidi Overton, President Trump’s nominee to lead the Food and Drug Administration, was grilled by senators on hot button topics like China, vaccines, and abortion access in her hearing before the committee that will decide whether to send her nomination for a vote of the full Senate

Heidi Overton has been nominated to lead the Food and Drug Administration at a moment of significant opportunity, but also big challenges. Innovation in medicine has never moved faster, providing more ways for Americans to improve their health and for the United States to advance the health of its population. But the institutions that carry…

Addiction clinics around the country are seeing a growing number of cases related to gas station products made from the kratom leaf and its derivatives.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Shares in Grail, the company developing a blood test aimed at detecting many different types of cancer early, when they can be treated more effectively, surged 33% Monday after the Food and Drug Administration posted documents ahead of an advisory committee meeting that suggest the agency may take a favorable view of the test.